Educational lecture on ventricular tachyarrhythmia.
نویسندگان
چکیده
منابع مشابه
Educational Lecture
― ― S30 ― US FDA is a regulatory body to regulate not only drugs but also medical devices, biological products, cell therapy products, cosmetics and food additives. The largest laboratory animal users are laboratories that follow the government requirement for safety testing and the amendment of GLP regulation is interested in by laboratory animal industry. In USA, GLP is regulated by law inste...
متن کاملLorcainide in patients with refractory ventricular tachyarrhythmia.
Lorcainide, a new antiarrhythmic agent with local anesthetic or membrane-stabilizing properties similar to those of quinidine, was tested in 76 patients with diverse types of heart disease and recurrent ventricular tachycardia or ventricular fibrillation. Lorcainide was administered for 72 to 96 hours in a dose ranging from 200 to 400 mg daily. Evaluation of drug efficacy involved ambulatory mo...
متن کاملCatheter ablation for ventricular tachyarrhythmia in patients with channelopathies
Drug treatment and/or implantable cardioverter defibrillator (ICD) implantation are the most widely accepted first-line therapies for channelopathic patients who have recurrent syncope, sustained ventricular tachycardia (VT), or documented ventricular fibrillation (VF), or are survivors of cardiac arrest. In recent years, there have been significant advances in mapping techniques and ablation t...
متن کاملVentricular tachyarrhythmia as a primary presentation of sarcoidosis.
AIMS Sarcoidosis is a multisystem, granulomatous disease with occasional cardiac manifestations. The clinical course of patients with ventricular tachyarrhythmias as a primary presentation of sarcoidosis is mostly unknown. METHODS AND RESULTS We describe nine patients (four males and five females) in whom sarcoidosis manifested as ventricular tachycardia (VT). The age of the patients was 53 +...
متن کاملT Wave Alternans And Ventricular Tachyarrhythmia Risk Stratification: A Review
Sudden cardiac death (SCD) is one of the leading causes of mortality in industrialized countries. Thus, identifying patients at high risk of SCD is an important goal. T wave alternans (TWA) is a new method for identifying patients with lethal ventricular tachyarrhythmias, and is dependent on heart rate. The maximal predictive accuracy is achieved at heart rates between 100 and 120 bpm, so that ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nihon Naika Gakkai Zasshi
سال: 1990
ISSN: 0021-5384,1883-2083
DOI: 10.2169/naika.79.1272